DXR is Daxor Corporation (Healthcare) — a non-dividend-paying stock. Trading at $10.00. Market cap: $63M.
Stock snapshot
| Price | $10.00 |
| Market cap | $63M |
| Sector | Healthcare |
| Exchange | NCM |
| Pays dividend | No |
About DXR
Daxor Corp is a medical instrumentation and biotechnology company focused on blood volume measurement. The company develops and markets the BVA-100 (Blood Volume Analyzer), the first diagnostic blood test cleared by the FDA offers unmatched, real-time, precise data via its rapid, hand-held, lab-based system. The company operates as a single business segment centered on the development, commercialization, and support of its proprietary blood volume analysis technology used by healthcare providers.
Related non-dividend companies
Other non-dividend stocks investors research alongside DXR. Peer set from Massive news + returns similarity, filtered to names we currently track.
Frequently asked
What is DXR's current stock price?
DXR (Daxor Corporation) is currently trading at $10.00.
Does DXR pay a dividend?
DXR (Daxor Corporation) does not currently pay a regular dividend.
Track DXR in DiviDrip
Add DXR to your watchlist on DiviDrip to monitor price, fundamentals, and Capital Quality Rank week-over-week. Built for long-term investors tracking both dividend and non-dividend names.
- Open DiviDrip — search DXR and add it to your watchlist.
- Stock Screener — filter by sector, market cap, and Capital Quality Rank.
- How to use the Screener — sector / quality / market-cap filters explained.
Data refreshed 2026-09-03. Not investment advice. Prices change continuously; always verify the latest numbers in the live app before buying.